Committed to sharing our science

Committed to sharing our science

391 results available

Evaluation of Aficamten or Beta-Blocker Monotherapy Versus Placebo in Patients with Obstructive Hypertrophic Cardiomyopathy: A Pooled Analysis of SEQUOIA-HCM and MAPLE-HCM

Poster, ACC 2026

Schulze, PC et al.

March 30, 2026
Electrocardiographic Changes and Associations with Echocardiographic Changes in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the SEQUOIA-HCM Trial

Poster, ACC 2026

Foa, A et al.

March 29, 2026
Aficamten Versus Metoprolol in Patients with Hypertension and Obstructive Hypertrophic Cardiomyopathy

Poster, ACC 2026

Masri, A et al.

March 28, 2026
Clinical Implications Associated With Temporary Treatment Interruption and Reinitiation of Aficamten Therapy in Obstructive Hypertrophic Cardiomyopathy

Oral Presentation, ACC 2026

Maron, MS et al.

March 29, 2026
Effect of the Cardiac Myosin Activator Omecamtiv Mecarbil on Ventricular Arrhythmias, Cardiac Arrest, and Sudden Death in Heart Failure With Reduced Ejection Fraction: The GALACTIC-HF Trial

European Journal of Heart Failure

Foa, A et al.

February 12, 2026